Info:

Cho is a post-doctoral fellow with Dr. Barry Forman at the City of Hope, National Medical Center at the Beckman Research Institute in California. His research interests include nuclear receptor signaling. His current project is: Novel Pathways for orphan receptor action.

Publications:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=search&term=Cho%2Byc

• Cho YC, Zheng W, Yamamoto M, Liu X, Hanlon PR, and Jefcoate CR. (2005). Differentiation of pluripotent C3H10T1/2 cells rapidly elevates CYP1B1 through a novel process that overcomes a loss of Ah Receptor.  Arch Biochem Biophys. 439:139-153. PDF PMID 15967407
  
  
• Hanlon PR, Cimafranca MA, Liu X, Cho YC, and Jefcoate CR. (2005). Microarray analysis of early adipogenesis in C3H10T1/2 cells: cooperative inhibitory effects of growth factors and 2,3,7,8-tetrachloro-dibenzo-p-dioxin.  Toxicol Appl Pharmacol.  207:39-58. PDF PMID 16054899
  
  
• Cho YC and Jefcoate CR. (2004). PPARg1 Synthesis and adipogenesis in C3H10T1/2 cells depends on S-Phase progression, but does not require mitotic clonal expansion. J Cell Biochem. 91:336-353. PMID 14743393
  
  
• Hanlon PR, Ganem LG, Cho YC, Yamamoto M, and Jefcoate CR. (2003). AhR- and ERK-dependent pathways function synergistically to mediate 2,3,7,8-tetrachlorodibenzo-p-dioxin suppression of peroxisome proliferator-activated receptor-gamma1 expression and subsequent adipocyte differentiation. Toxicol Appl Pharmacol. 189:11-27. PDF PMID 12758056